1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. British Columbia >
  6. Telix Pharmaceuticals Acquires Artms

M&A Deal Summary

Telix Pharmaceuticals Acquires Artms

On March 5, 2024, Telix Pharmaceuticals acquired life science company Artms

Acquisition Highlights
  • This is Telix Pharmaceuticals’ 4th transaction in the Life Science sector.
  • This is Telix Pharmaceuticals’ 1st transaction in Canada.
  • This is Telix Pharmaceuticals’ 1st transaction in British Columbia.

M&A Deal Summary
Date 2024-03-05
Target Artms
Sector Life Science
Buyer(s) Telix Pharmaceuticals
Deal Type Add-on Acquisition

Target

Artms

Burnaby, British Columbia, Canada
Artms is a commercial-stage company that specializes in the physics, chemistry, and materials science of cyclotron-produced radionuclides. Its technology is used by the major manufacturing networks to optimize the production of a range of medical radioisotopes. Artms is based in Burnaby, British Columbia.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Telix Pharmaceuticals

North Melbourne, Australia
Category Company
Sector Life Science
DESCRIPTION

Telix Pharmaceuticals Ltd. is a clinical-stage biopharamaceutical company headquartered in Melbourne, Australia. Telix is developing an advanced portfolio of clinical-stage products that address significant unmet medical need in oncology, particularly renal, prostate and brain (glioblastoma) cancer.

DEAL STATS #
Overall 5 of 7
Sector: Life Science M&A 4 of 6
Type: Add-on Acquisition M&A Deals 3 of 4
State: British Columbia M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2024 M&A 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2024-02-27 IsoTherapeutics

Angleton, Texas, United States

IsoTherapeutics is a privately held, commercial-stage company, which provides radiochemistry and bioconjugation development and contract manufacturing services. IsoTherapeutics was founded in 2005 and is based in Angleton, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-12-23 RLS Radiopharmacies

Lake Mary, Florida, United States

RLS Radiopharmacies is a General Electric Channel Partner engaged in isotope production and delivery of service to the nuclear medicine market. RLS Radiopharmacies is based in Lake Mary, Florida.

Buy $230M
Mergr

Solution for

Product

Company

Legal